PCIF1 and Alzheimer disease: However, the pathological roles of neuronal METTL3 reduction and RNA m6A dysregulation in AD are unlikely affected by this limitation, since a cap-specific adenosine methyltransferase (CAPAM) is responsible for m6Am modification [74].